HCR 172 Hawaii House · 2026 Regular Session

REQUESTING THE AUDITOR TO CONDUCT A PERFORMANCE AND PROCUREMENT AUDIT OF THE DEPARTMENT OF HUMAN RESOURCES DEVELOPMENT TO REVIEW ITS COMPLIANCE WITH THE HAWAII PUBLIC PROCUREMENT CODE.

This bill requests the State Auditor to conduct a performance and procurement audit of the Department of Human Resources Development (DHRD) to examine its compliance with Hawaii's public procurement laws and its management of workers' compensation prescription drug claims. The audit will review procurement actions taken by DHRD over the past five years, assess adherence to procurement statutes, and evaluate documentation for non-competitive purchasing methods. It also aims to identify systemic issues contributing to delays or denials in workers' compensation benefits and provide recommendations for improving accountability and efficiency within the department. The Auditor is required to submit a report with findings and recommendations to the Legislature by the start of the 2027 session.

Bill status passed 3 of 5 stages cleared

Introduction

Mar 2026

Committee Review

Apr 2026

House Passage

Apr 2026

Senate Passage

Governor

Introduced Mar 16, 2026 Last action Apr 2, 2026

Maddy AI version diff · 1 comparison

What changed between versions

HCR172 → HCR172_HD1 · 3 edits

MINOR

The bill was revised to remove a specific request for the Auditor to review workers' compensation prescription drug claims, narrowing the audit's primary focus to general procurement compliance. Additionally, the bill was renumbered from HCR 172 to HCR 172 HD1, indicating it has been amended by the House of Representatives.

Scope change

The scope of the requested audit was narrowed by removing the specific mandate to review prescription drug claims, focusing instead on general procurement compliance.

REQUIREMENT

Removed the specific request for the Auditor to conduct a performance audit regarding workers' compensation prescription drug claims.

Modified the audit scope to focus solely on reviewing compliance with the Hawaii Public Procurement Code, removing the specific mention of prescription drug claims.

TECHNICAL

Changed the bill title from HCR 172 to HCR 172 HD1 and updated metadata to reflect House amendments.

Floor votes

How they voted

This bill passed the House by voice vote (no roll call recorded).

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Apr 2, 2026

Lower · Passed

Report adopted; referred to the committee(s) on FIN as amended in HD 1 with none voting aye with reservations; none voting no (0) and none excused (0).

lower

Apr 2, 2026

Committee

Reported from LAB (Stand. Com. Rep. No. 1705-26) as amended in HD 1, recommending referral to FIN.

lower

Mar 31, 2026

Lower · Passed

The committee on LAB recommend that the measure be PASSED, WITH AMENDMENTS. The votes were as follows: 5 Ayes: Representative(s) Sayama, Lee, M., Kapela, Kong, Reyes Oda; Ayes with reservations: none; 0 Noes: none; and 1 Excused: Representative(s) Garrett.

lower

Mar 18, 2026

Committee

Referred to LAB, FIN, referral sheet 19

lower

Mar 16, 2026

Introduced

Offered

lower

1 primary · 0 co-sponsors